Publications by authors named "Ton Slagboom"

Claim this Profile
C
Cardiac troponin for the diagnosis of acute myocardial infarction in patients after out-of-hospital cardiac arrest.
Bas J Verkaik, Christian van der Werf, Johan C Fischer, Raymond Tukkie, Victor A W M Umans, Ton Slagboom

Resuscitation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sheath Type on Vascular and Bleeding Complications After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the MARVEL Registry Study.
Emily Pan, Herbert G Kroon, Pim A L Tonino, Giovanni Amoroso, Mika Laine, Ton Slagboom

Catheter Cardiovasc Interv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Year Clinical Outcomes of Paclitaxel-Coated Balloon Angioplasty vs DES in Acute MI: The REVELATION Trial.
Sander R Niehe, Nicola S Vos, René J Van Der Schaaf, Giovanni Amoroso, Jean-Paul R Herrman, Ton Slagboom

JACC Cardiovasc Interv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
Raghava S Velagaleti, Camden Harrell, Justin Michalski, Thierry Lefèvre, Stephan Windecker, Ton Slagboom

Catheter Cardiovasc Interv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.
Alexandra J Lansky, Bo Xu, Andreas Baumbach, Henning Kelbæk, Niels van Royen, Ton Slagboom

EuroIntervention· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.
Hugo M Aarts, Nicole D van Hemert, Timion A Meijs, Astrid C van Nieuwkerk, Jurriën M Ten Berg, Ton Slagboom

Neth Heart J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries.
Thomas Oomens, Nicola S Vos, René J van der Schaaf, Giovanni Amoroso, Mark M Ewing, Ton Slagboom

Int J Cardiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.
Ton Slagboom, Ralph Toelg, Bernhard Witzenbichler, Michael Haude, Monica Masotti

EuroIntervention· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial.
Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Ton Slagboom

J Am Heart Assoc· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pronounced late acquired focal coronary artery dilatation after paclitaxel-coated balloon angioplasty: observations from the randomized REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION (REVELATION) trial.
Nicola S Vos, Giovanni Amoroso, Jean-Paul R Herrman, Mark S Patterson, René J van der Schaaf, Ton Slagboom

Coron Artery Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.
Felice Gragnano, Dik Heg, Anna Franzone, Eugène P McFadden, Sergio Leonardi, Ton Slagboom

Eur Heart J Cardiovasc Pharmacother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
Sander R Niehe, Nicola S Vos, René J Van Der Schaaf, Giovanni Amoroso, Jean-Paul R Herrman, Ton Slagboom

J Invasive Cardiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
Ralph Toelg, Ton Slagboom, Johannes Waltenberger, Thierry Lefèvre, Shigeru Saito

Catheter Cardiovasc Interv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
Nick D Fagel, Giovanni Amoroso, Tanja Rabbering, Froukje Gescher, Maarten A Vink, Ton Slagboom

Catheter Cardiovasc Interv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.
Rayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, Nader Mankerious, Abdelhakim Allali, Ton Slagboom

J Am Heart Assoc· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dedicated plug based closure for large bore access -The MARVEL prospective registry.
Herbert G Kroon, Pim A L Tonino, Mikko Savontaus, Giovanni Amoroso, Mika Laine, Ton Slagboom

Catheter Cardiovasc Interv· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials.
Thomas Pilgrim, Martina Rothenbühler, George Cm Siontis, David E Kandzari, Juan F Iglesias, Ton Slagboom

Am Heart J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial.
Nick D Fagel, Giovanni Amoroso, Maarten A Vink, Ton Slagboom, René J van der Schaaf

Am Heart J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional variation in patients and outcomes in the GLOBAL LEADERS trial.
Chao Gao, Kuniaki Takahashi, Scot Garg, Hironori Hara, Rutao Wang, Ton Slagboom

Int J Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.
Sergio Leonardi, Mattia Branca, Anna Franzone, Eugene McFadden, Raffaele Piccolo, Ton Slagboom

Circ Cardiovasc Qual Outcomes· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.
Chao Gao, Piotr Buszman, Paweł Buszman, Ply Chichareon, Rodrigo Modolo, Ton Slagboom

Can J Cardiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, Hideyuki Kawashima, Rutao Wang, Ton Slagboom

Cardiovasc Diabetol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months.
Shigeru Saito, Ralph Toelg, Bernhard Witzenbichler, Michael Haude, Monica Masotti, Ton Slagboom

EuroIntervention· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.
Anna Franzone, Eugène McFadden, Sergio Leonardi, Raffaele Piccolo, Pascal Vranckx, Ton Slagboom

J Am Coll Cardiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.
Ply Chichareon, Rodrigo Modolo, Carlos Collet, Erhan Tenekecioglu, Maarten A Vink, Ton Slagboom

J Am Coll Cardiol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis